Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghui Zhou

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Pharmacology|October 20, 2006
Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Honghui Zhou
Journal of Clinical Pharmacology|April 20, 2007
Biologics in the pipeline: large molecules with high hopes or bigger risks?Honghui Zhou
Journal of Clinical Pharmacology|April 16, 2005
Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion proteinHonghui Zhou
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetic strategies in deciphering atypical drug absorption profilesHonghui Zhou
Journal of Pharmacokinetics and Pharmacodynamics|November 11, 2015
Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritisChuanpu Hu, Honghui Zhou
Journal of Clinical Pharmacology|January 11, 2012
Characterizing the impact of renal impairment on the clinical pharmacology of biologicsBernd Meibohm, Honghui Zhou
Journal of Pharmacokinetics and Pharmacodynamics|November 25, 2015
Erratum to: Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritisChuanpu Hu, Honghui Zhou
Journal of Clinical Pharmacology|September 4, 2007
Pharmacokinetic drug-drug interaction potentials for therapeutic monoclonal antibodies: reality checkKathleen Seitz, Honghui Zhou
Drug Discovery Today. Technologies|December 17, 2016
Pharmacological considerations for predicting PK/PD at the site of action for therapeutic proteinsWeirong Wang, Honghui Zhou
Journal of Pharmacokinetics and Pharmacodynamics|November 20, 2021
Improving categorical endpoint longitudinal exposure-response modeling through the joint modeling with a related endpointChuanpu Hu, Honghui Zhou
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacology|October 20, 2006
Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Honghui Zhou
Journal of Clinical Pharmacology|April 20, 2007
Biologics in the pipeline: large molecules with high hopes or bigger risks?Honghui Zhou
Journal of Clinical Pharmacology|April 16, 2005
Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion proteinHonghui Zhou
Journal of Clinical Pharmacology|March 18, 2003
Pharmacokinetic strategies in deciphering atypical drug absorption profilesHonghui Zhou
Journal of Pharmacokinetics and Pharmacodynamics|November 11, 2015
Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritisChuanpu Hu, Honghui Zhou
Journal of Clinical Pharmacology|January 11, 2012
Characterizing the impact of renal impairment on the clinical pharmacology of biologicsBernd Meibohm, Honghui Zhou
Journal of Pharmacokinetics and Pharmacodynamics|November 25, 2015
Erratum to: Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritisChuanpu Hu, Honghui Zhou
Journal of Clinical Pharmacology|September 4, 2007
Pharmacokinetic drug-drug interaction potentials for therapeutic monoclonal antibodies: reality checkKathleen Seitz, Honghui Zhou
Drug Discovery Today. Technologies|December 17, 2016
Pharmacological considerations for predicting PK/PD at the site of action for therapeutic proteinsWeirong Wang, Honghui Zhou
Journal of Pharmacokinetics and Pharmacodynamics|November 20, 2021
Improving categorical endpoint longitudinal exposure-response modeling through the joint modeling with a related endpointChuanpu Hu, Honghui Zhou
Pageof 15